Boston Cell Standards
Our story began in 2003. One of the BCS founders, Dr. Steve Bogen, had just sold the Artisan® special stainer (histopathology) product line to Dako Corp. (now Agilent) and returned to academia as Medical Director of the clinical chemistry laboratory, Boston Medical Center. That transition highlighted the contrast in laboratory practice between tissue (histopathology) vs. blood (clinical chemistry) diagnostic testing. Basic quality systems in clinical chemistry, such as reference standards, measurement traceability, units of measure, and Levey-Jennings QC analysis, were unheard-of in immunohistochemistry (histopathology).
Content by Boston Cell Standards
|2 min read
Consortium for Analytic Standardization in Immunohistochemistry
Group of renowned pathologists and scientists aims to improve patient immunohistochemistry (IHC) test accuracyPage 1 of 1




